Abstract:Ethnopharmacological relevanceThe Jinwu Gutong (JWGT) capsule is a Chinese patent medicine that is widely used in the treatment of knee osteoarthritis (KOA) and osteoporosis in China and is considered to have the potential for good clinical efficacy.Aim of the studyThe purpose of this study was to systematically evaluate the clinical efficacy and safety of JWGT in the treatment of KOA.Materials and methodsWe searched the China National Knowledge Infrastructure (CNKI), Wanfang, SinoMed, PubMed, Embase and Cochrane Library databases to identify clinical trials that explore the use of JWGT only or JWGT combined with Western drugs (JWGT group) compared with the use of conventional Western drugs (Western drugs group) for the treatment of KOA. The clinical trials, that were retrieved from each database from the inception of the database to December 2021, were screened. We used the risk of bias assessment tool recommended by Cochrane to evaluate the quality of the included literature and RevMan 5.3 software for data analysis.ResultsA total of 17 clinical randomized controlled trials (RCTs) were included in this study, with a total of 1930 participants, including 1015 people in the experimental group and 915 people in the control group. The results of the meta-analysis showed that the JWGT group exhibited better efficacy than the Western drug group with respect to WOMAC score (WMD = −6.25, 95% CI = −8.09 to −4.41, P < 0.001), VAS score (WMD = −1.36, 95% CI = −2.17 to −0.55, P = 0.001), KSS score (WMD = 23.01, 95% CI = 21.42 to 24.59, P < 0.001), IL-6 (SMD = −3.30, 95% CI = −4.84 to −1.76, P < 0.001), TNF-α (SMD = −1.70, 95% CI = −2.02 to −1.38, P < 0.001). The effective rate (OR = 2.56, 95% CI = 1.83 to 3.57, P < 0.001) and incidence of adverse reactions was significantly lower in the JWGT group than in the control group (OR = 0.13, 95% CI = 0.07 to 0.21, P < 0.001). Subgroup analysis showed that JWGT + NSAIDs had more advantages in regard to efficacy (OR = 2.05, 95% CI = 1.35 to 3.12, P < 0.001), and reducing adverse reactions (OR = 0.10, 95% CI = 0.06 to 0.18, P < 0.001), VAS score (WMD = −1.00, 95% CI = −1.93 to −0.07, P = 0.04), KSS score (WMD = 17.39, 95% CI = 15.39 to 19.39, P < 0.001), WOMAC score (WMD = −2.84, 95% CI = −10.75 to 5.08, P < 0.001), IL-6 (SMD = −1.42, 95% CI = −2.08 to −0.75, P < 0.001) and TNF-α (SMD = −1.68, 95% CI = −1.93 to −1.43, P < 0.001) than NSAIDs alone. Compared with hyaluronic acid (HA) alone, JWGT + HA had better clinical efficacy (OR = 3.08, 95% CI = 1.48 to 6.40, P < 0.001). Compared with glucosamine (GS) alone, JWGT + GS significantly reduced the Lequesne index score (WMD = −0.53, 95% CI = −0.85 to −0.21, P = 0.001) and the serum TNF-α level (SMD = −1.68, 95% CI = −1.93 to −1.43, P < 0.001), but it had no significant advantage in reducing the serum IL-6 level (SMD = −4.53, 95% CI = −10.13 to 1.07, P = 0.11).ConclusionJWGT is considered effective and safe in the treatment of KOA and is worthy of clinical application. In addition, the application of JWGT combined with NSAIDs, HA or GS can significantly improve the clinical efficacy of the latter agents in KOA treatment.

Treatment of knee osteoarthritis patients with Gulong capsules:a multi-center randomized controlled study

The efficacy and safety of Xianling Gubao capsules in the treatment of knee osteoarthritis: A protocol for a randomized, double-blind, controlled trial

Clinical Study of Shuangyi Qushi Tongluo Capsules in Treating Knee Osteoarthritis

Clinical Study of Xianlinggubao Capsule in the Treatment of Knee Osteoarthritis

The efficacy and safety of Jinwu Gutong capsule in the treatment of knee osteoarthritis: A meta-analysis of randomized controlled trials

Therapeutic effect of San Bi Tang combined with glucosamine sulfate capsules in cold-dampness-type knee osteoarthritis

Combined use of compound nanxing pain paste with blood-promoting and diuretic chinese herbal medicines in treatment of chronic knee synovitis]

Efficacy and safety of combined Chinese and Western medicine in the treatment of knee osteoarthritis: a prospective, multicenter cohort study

Clinical Efficacy of Qizhengxiaotong Plaster Plus Xianling Gubao for Osteoarthritis of Knee

Lingze Tablets for BPH with Kidney-Deficiency,blood Stasis and Dampness Resistance:A Phase-ⅳ Open-Label Single-Arm Multicenter Clinical Study and Safety Evaluation

Zhuifeng Tougu capsules in the treatment of knee osteoarthritis (cold dampness obstruction syndrome): a randomized, double blind, multicenter clinical study

[Clinical comprehensive evaluation of Ruyi Zhenbao Pills in treatment of osteoarthritis]

Effect of glucosamine hydrochloride in ameliorating knee osteoarthritis

[A Multi-Central, Randomized, Controlled Clinical Trial of Glucosamine Hydrochloride/sulfate in the Treatment of Knee Osteoarthritis].

Stage-based Treatment of Gouty Arthritis by Combination Therapy of Traditional Chinese and Western Medicines: a Randomized Controlled Trial

Efficacy and safety of Tuina (Chinese Therapeutic Massage) for knee osteoarthritis: A randomized, controlled, and crossover design clinical trial

The Effectiveness of Tuina in Relieving Pain, Negative Emotions, and Disability in Knee Osteoarthritis: A Randomized Controlled Trial

[Randomized,double-blind,parallel controlled,multicenter clinical trial of effectiveness and safety of Shexiang Zhuifeng Zhitong Ointment in alleviating pain in knee osteoarthritis(syndrome of cold-dampness obstruction)]

Effectiveness of glucosamine chondroitin sulfate calcium tablets for knee osteoarthritis

Chinese Medicine Involving Triple Rehabilitation Therapy for Knee Osteoarthritis in 696 Outpatients: A Multi-Center, Randomized Controlled Trial

Bioinformatics analysis combined with experimental validation to explore the mechanism of XianLing GuBao capsule against osteoarthritis